Mice lacking neutral amino acid transporter B0AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control
Objective: Type 2 diabetes arises from insulin resistance of peripheral tissues followed by dysfunction of β-cells in the pancreas due to metabolic stress. Both depletion and supplementation of neutral amino acids have been discussed as strategies to improve insulin sensitivity. Here we characterise...
Saved in:
Main Authors: | Yang Jiang (Author), Adam J. Rose (Author), Tjeerd P. Sijmonsma (Author), Angelika Bröer (Author), Anja Pfenninger (Author), Stephan Herzig (Author), Dieter Schmoll (Author), Stefan Bröer (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
by: Angelika Bröer, et al.
Published: (2018) -
Novel Chemical Scaffolds to Inhibit the Neutral Amino Acid Transporter B0AT1 (SLC6A19), a Potential Target to Treat Metabolic Diseases
by: Aditya Yadav, et al.
Published: (2020) -
Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells
by: Gregory Gauthier-Coles, et al.
Published: (2022) -
Repletion of branched chain amino acids reverses mTORC1 signaling but not improved metabolism during dietary protein dilution
by: Adriano Maida, et al.
Published: (2017) -
Socioeconomic Inequality and Educational Outcomes Evidence from Twenty Years of TIMSS
by: Broer, Markus
Published: (2019)